S. Tinlin

发表

The Canadian "National Program for hemophilia mutation testing" database: a ten-year review.

J. Leggo, P. James, D. Lillicrap, 2013, American journal of hematology.

Aberrant Splicing and Premature Termination of Transcription of the FVIII Gene as a Cause of Severe Canine Hemophilia A: Similarities with the Intron 22 Inversion Mutation in Human Hemophilia

A. Giles, D. Lillicrap, C. Hough, 2002, Thrombosis and Haemostasis.

A canine model of hemophilic (factor VIII:C deficiency) bleeding.

A. Giles, S. Tinlin, R. Greenwood, 1982, Blood.

In vivo studies of the role of factor VII in hemostasis.

A. Giles, S. Tinlin, H. Hoogendoorn, 1985, Blood.

The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study.

L. O'Brien, J. Leggo, M. Othman, 2007, Blood.

Changes in the pattern of distribution of von Willebrand factor in rat aortic endothelial cells following thrombin generation in vivo

A. Giles, Y. Senis, S. Tinlin, 1996, British journal of haematology.

Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs.

M. Kaleko, S. Connelly, D. Lillicrap, 2001, Blood.

The Factor VIII Acute Phase Response Requires the Participation of NFκB and C/EBP

D. Lillicrap, S. Tinlin, C. Notley, 2000, Thrombosis and Haemostasis.

Sustained phenotypic correction of canine hemophilia A using an adeno-associated viral vector.

A. Parker, J. F. Wright, L. Couto, 2003, Blood.

The genetics of Canadian type 3 von Willebrand disease: further evidence for co‐dominant inheritance of mutant alleles

V. Blanchette, J. Leggo, P. James, 2013, Journal of thrombosis and haemostasis : JTH.

The Canadian “National Program for hemophilia mutation testing” database: A ten‐year review

J. Leggo, P. James, D. Lillicrap, 2013, American journal of hematology.

Factors influencing therapeutic efficacy and the host immune response to helper‐dependent adenoviral gene therapy in hemophilia A mice

F. Graham, C. Shi, B. Brown, 2004, Journal of thrombosis and haemostasis : JTH.

In vivo characterization of recombinant factor VIII in a canine model of hemophilia A (factor VIII deficiency).

A. Giles, S. Tinlin, N. Pancham, 1988, Blood.

Development of factor VIII:C antibodies in dogs with hemophilia A (factor VIII:C deficiency)

A. Giles, S. Tinlin, P. Greenwood, 1984 .

Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian Type 1 VWD Study

A. Paterson, L. O'Brien, J. Leggo, 2006, Journal of thrombosis and haemostasis : JTH.

The Development of Homologous (Canine/Anti-Canine) Antibodies in Dogs with Haemophilia A (Factor VIII Deficiency): A Ten-Year Longitudinal Study

A. Giles, S. Tinlin, S. Webster, 1993, Thrombosis and Haemostasis.

biphasic liver toxicity in hemophilia A dogs results in short-term phenotypic correction, inhibitor development, and Systemic delivery of an adenoviral vector encoding canine factor VIII

M. Kaleko, S. Connelly, D. Lillicrap, 2013 .

In vivo evaluation of an adenoviral vector encoding canine factor VIII: high-level, sustained expression in hemophiliac mice.

D. Kayda, M. Kaleko, S. Connelly, 1999, Human gene therapy.

The thrombogenicity of prothrombin complex concentrates. IV. The source of coagulant-active phospholipid.

A. Giles, S. Tinlin, H. Hoogendoorn, 1984, Thrombosis research.

In vivo characterization of recombinant factor VIII in a canine model of hemophilia A (factor VIII deficiency).

A. Giles, S. Tinlin, N. Pancham, 1988, Blood.

Heterogeneity of the immune response to adenovirus‐mediated factor VIII gene therapy in different inbred hemophilic mouse strains

F. Graham, B. Brown, D. Lillicrap, 2004, The journal of gene medicine.

A platelet release defect induced by aspirin or penicillin G does not increase gastrointestinal blood loss in thrombocytopenic rabbits

A. Giles, S. Tinlin, Penny Greenwood And, 1984, British journal of haematology.

Morphological alterations in endothelial cells associated with the release of von Willebrand factor after thrombin generation in vivo.

A. Giles, Y. Senis, S. Tinlin, 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

Development of factor VIII:C antibodies in dogs with hemophilia A (factor VIII:C deficiency).

A. Giles, S. Tinlin, P. Greenwood, 1984, Blood.

VIII : C deficiency ) Development of factor VIII : C antibodies in dogs with hemophilia A ( factor

S. Tinlin, P. Greenwood, H. Hoogendoorn, 2005 .